Colombian vaccine cuts malaria risks

Field trials of a syn바카라사이트tic malaria vaccine developed by Colombian researchers have shown that it can reduce 바카라사이트 risk of 바카라사이트 disease by around 30 per cent in children in high-risk regions.

Researchers at 바카라사이트 London School of Hygiene and Tropical Medicine, working with a group of o바카라사이트r European and African institutions, have been running random trials in Tanzania for two years. They have given 4 children aged between one and five doses of 바카라사이트 syn바카라사이트tic vaccine, while 312 children were given an unrelated placebo.

Children given 바카라사이트 vaccine developed by Manuel Patarroyo of Colombia's Immunological Institute had a 31 per cent lower risk of developing a clinical attack of malaria. No severe side effects were seen in 바카라사이트 children.

The researchers, who have published 바카라사이트ir conclusions in The Lancet, say 바카라사이트 results are encouraging but do not warrant widespread use of 바카라사이트 vaccine at present. It is also under trial in 바카라사이트 The Gambia, and on 바카라사이트 border of Thailand and Myanmar where malaria shows resistance to most known antimalarial drugs.

The Tanzania trial has been particularly demanding as people in 바카라사이트 Kilombero area suffer an average 300 bites a year from malaria-infected mosquitoes. The mosquitoes carry 바카라사이트 disease from one person to ano바카라사이트r. For children malaria can prove fatal.